Details of Viral Vaccine
This Viral vaccine card gives comprehensive information about each vaccine.
| Detailed Information | |
|---|---|
| ID | 10026 |
| Vaccine Name | Comirnaty |
| Disease Name | COVID-19 |
| Disease Classification | Respiratory |
| Virus Name | SARS-CoV-2 virus |
| Nucleic Acid Content | positive-sense, single-stranded RNA |
| Vaccine Type | RNA based vaccine |
| Vaccine Status | Approved |
| Manufacturer | BioNTech SE, Pfizer Inc. |
| Year of Manufacturing | NA |
| Manufacturing Country | USA |
| Age | 12 years and above |
| Dosage | 2 doses 3 weeks apart |
| Administration Route | Intramuscular |
| Adjuvant | NA |
| Target Strain | Trimerized SARS-CoV-2 receptor-binding domain from spike protein |
| Description | mRNA based vaccine |
| Approving Organisation | US FDA |
| Collaborating Organisation | NA |
| Other Countries | Argentina, Canada, Chile, Costa Rica, Ecuador, Jordan, Kuwait, Mexico, Panama, Singapore, Bahrain, Saudi Arabia, Switzerland, European Union |
| Trade Name | BNT162b2, COVID-19 mRNA vaccine, Tozinameran |
| PMID | 33826439 |
| Clinical Trial ID | NA |
| Reference Link | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8040490// |
| Additional Links | https://www.comirnaty.com/ |